Search
Search results
254 results found
Correction: SCFβ-TRCP suppresses angiogenesis and thyroid cancer cell migration by promoting ubiquitination and destruction of VEGF receptor 2.
Shaik, Shavali, Carmelo Nucera, Hiroyuki Inuzuka, Daming Gao, Maija Garnaas, Gregory Frechette, Lauren Harris, et al. 2025. “Correction: SCFβ-TRCP Suppresses Angiogenesis and Thyroid Cancer Cell Migration by Promoting Ubiquitination and Destruction of VEGF Receptor 2.”. The Journal of Experimental Medicine 222 (9).
Therapeutic treatments targeting communication between angiogenic and immune microenvironments in thyroid cancers.
Prete, Alessandro, and Carmelo Nucera. 2024. “Therapeutic Treatments Targeting Communication Between Angiogenic and Immune Microenvironments in Thyroid Cancers.”. Current Opinion in Endocrine and Metabolic Research 37.
Case Report of CCDC149-ALK Fusion: A Novel Genetic Alteration and a Clinically Relevant Target in Metastatic Papillary Thyroid Carcinoma.
Lee, Hannah, Vimal Krishnan, Lori J Wirth, Carmelo Nucera, Mariza Venturina, Peter M Sadow, Alain Mita, and Wendy Sacks. 2022. “Case Report of CCDC149-ALK Fusion: A Novel Genetic Alteration and a Clinically Relevant Target in Metastatic Papillary Thyroid Carcinoma.”. Thyroid : Official Journal of the American Thyroid Association 32 (12): 1580-85.
Role of Regulatory Non-Coding RNAs in Aggressive Thyroid Cancer: Prospective Applications of Neural Network Analysis.
Iesato, Asumi, and Carmelo Nucera. 2021. “Role of Regulatory Non-Coding RNAs in Aggressive Thyroid Cancer: Prospective Applications of Neural Network Analysis.”. Molecules (Basel, Switzerland) 26 (10).
Corrigendum: Thrombospondin-1 Silencing Down-Regulates Integrin Expression Levels in Human Anaplastic Thyroid Cancer Cells With BRAFV600E: New Insights in the Host Tissue Adaptation and Homeostasis of Tumor Microenvironment.
Duquette, Mark, Peter M Sadow, Jack Lawler, and Carmelo Nucera. 2020. “Corrigendum: Thrombospondin-1 Silencing Down-Regulates Integrin Expression Levels in Human Anaplastic Thyroid Cancer Cells With BRAFV600E: New Insights in the Host Tissue Adaptation and Homeostasis of Tumor Microenvironment.”. Frontiers in Endocrinology 11: 596223.
Role of BRAFV600E in the first preclinical model of multifocal infiltrating myopericytoma development and microenvironment.
Sadow, Peter M, Carmen Priolo, Simona Nanni, Florian A Karreth, Mark Duquette, Roberta Martinelli, Amjad Husain, et al. 2014. “Role of BRAFV600E in the First Preclinical Model of Multifocal Infiltrating Myopericytoma Development and Microenvironment.”. Journal of the National Cancer Institute 106 (8).
Targeting BRAFV600E with PLX4720 displays potent antimigratory and anti-invasive activity in preclinical models of human thyroid cancer.
Nucera, Carmelo, Matthew A Nehs, Sushruta S Nagarkatti, Peter M Sadow, Michal Mekel, Andrew H Fischer, Paul S Lin, et al. 2011. “Targeting BRAFV600E With PLX4720 Displays Potent Antimigratory and Anti-Invasive Activity in Preclinical Models of Human Thyroid Cancer.”. The Oncologist 16 (3): 296-309.
A novel orthotopic mouse model of human anaplastic thyroid carcinoma.
Nucera, Carmelo, Matthew A Nehs, Michal Mekel, Xuefeng Zhang, Richard Hodin, Jack Lawler, Vânia Nose, and Sareh Parangi. 2009. “A Novel Orthotopic Mouse Model of Human Anaplastic Thyroid Carcinoma.”. Thyroid : Official Journal of the American Thyroid Association 19 (10): 1077-84.
antiphospholipid antibodies syndrome associated with hyperhomocysteinemia related to MTHFR Gene C677T and A1298C heterozygous mutations in a young man with idiopathic hypoparathyroidism (DiGeorge syndrome).
Nucera, Carmelo, Mario Vaccaro, Mariacarla Moleti, Carmen Priolo, Gaetano Tortorella, Adriano Angioni, Riccardo Ientile, et al. 2006. “Antiphospholipid Antibodies Syndrome Associated With Hyperhomocysteinemia Related to MTHFR Gene C677T and A1298C Heterozygous Mutations in a Young Man With Idiopathic Hypoparathyroidism (DiGeorge Syndrome).”. The Journal of Clinical Endocrinology and Metabolism 91 (6): 2021-6.